concept

NEUROPATHY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

677Connections

0Hypotheses

0Analyses

25Outgoing

49Incoming

Summary

NEUROPATHY is a concept in neurodegeneration research. Key relationships include: co discussed, contributes to, treats. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 15 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	NEUROPATHY
Key Genes/Proteins	PINK1, PI3K, SOD1
Related Diseases	CANCER, DIABETES, NEURODEGENERATION, HYPERTENSION

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    NEUROPATHY["NEUROPATHY"]
    NEUROPATHY -->|"inhibits"| Lysosomal_Degradation["Lysosomal Degradation"]
    NEUROPATHY -->|"inhibits"| Blood_Brain_Barrier["Blood-Brain Barrier"]
    NEUROPATHY -->|"activates"| Inflammasome["Inflammasome"]
    NEUROPATHY -->|"activates"| Complement["Complement"]
    NEUROPATHY -->|"regulates"| Cholesterol["Cholesterol"]
    NEUROPATHY -->|"target for"| Apoptosis["Apoptosis"]
    NEUROPATHY -->|"target for"| Oxidative_Stress["Oxidative Stress"]
    NEUROPATHY -->|"target for"| Mitochondrial_Function["Mitochondrial Function"]
    FCGRT["FCGRT"] -->|"regulates"| NEUROPATHY
    NLRP3["NLRP3"] -->|"activates"| NEUROPATHY
    C1Q["C1Q"] -->|"activates"| NEUROPATHY
    P75NTR["P75NTR"] -->|"interacts"| NEUROPATHY
    VEGF["VEGF"] -->|"expressed in"| NEUROPATHY
    TNF["TNF"] -->|"expressed in"| NEUROPATHY
    MMP9["MMP9"] -->|"target for"| NEUROPATHY

Outgoing (195)

Target	Relation	Type	Str
CANCER	treats	disease	0.65
DIABETES	modifies	disease	0.65
SPINAL CORD	activates	brain_region	0.65
PINK1	regulates	gene	0.65
PI3K	treats	gene	0.65
SPHINGOLIPIDS	implicated_in	phenotype	0.55
BRAINSTEM	associated_with	brain_region	0.50
MFN2	associated_with	gene	0.50
CISPLATIN	associated_with	drug	0.45
OXALIPLATIN	associated_with	drug	0.45
PACLITAXEL	associated_with	drug	0.45
VINCRISTINE	associated_with	drug	0.45
NLRP3	associated_with	gene	0.45
IL18	associated_with	gene	0.45
RAB7	associated_with	gene	0.45
SOD1	associated_with	gene	0.45
METFORMIN	associated_with	drug	0.45
CURCUMIN	associated_with	drug	0.45
PARKIN	co_discussed	gene	0.40
PARKINSON	co_discussed	disease	0.40
PARKINSON'S	co_discussed	disease	0.40
PARKINSON'S DISEASE	co_discussed	disease	0.40
PACLITAXEL	activates	drug	0.35
RAB7	expressed_in	gene	0.35
SOD1	inhibits	gene	0.35

Incoming (482)

Source	Relation	Type	Str
DIABETES	causes	disease	0.65
DIABETES	treats	disease	0.65
NEURODEGENERATION	treats	disease	0.65
DIABETES	impairs	disease	0.65
DIABETES	increases_risk	disease	0.65
OXALIPLATIN	activates	drug	0.65
SOD1	targets	gene	0.65
HYPERTENSION	interacts_with	disease	0.65
BRAINSTEM	causes	brain_region	0.65
PACLITAXEL	causes	drug	0.65
PARKINSON'S DISEASE	regulates	disease	0.65
NEURONS	regulates	cell_type	0.65
TREM2	protects_against	gene	0.65
AXONAL TRANSPORT	activates	phenotype	0.65
CURCUMIN	activates	drug	0.65
TREM2	inhibits	gene	0.65
ASTROCYTE	inhibits	cell_type	0.65
HUNTINGTON	treats	disease	0.60
HUNTINGTON'S	treats	disease	0.60
ACHE	contributes_to	gene	0.60
DIABETES	contributes_to	disease	0.60
NEURODEGENERATION	contributes_to	disease	0.60
ASTROCYTE	causes	cell_type	0.60
CANCER	causes	disease	0.60
ACHE	impairs	gene	0.60
DIABETES	destabilizes	disease	0.60
SPHINGOLIPIDS	expressed_in	phenotype	0.55
DIABETES	interacts_with	disease	0.50
SPINAL CORD	associated_with	brain_region	0.50
OXALIPLATIN	associated_with	drug	0.45
VINCRISTINE	associated_with	drug	0.45
PACLITAXEL	associated_with	drug	0.45
BORTEZOMIB	associated_with	drug	0.45
CISPLATIN	associated_with	drug	0.45
ALZHEIMER	co_discussed	disease	0.40
ALZHEIMER'S	co_discussed	disease	0.40
ALZHEIMER'S DISEASE	co_discussed	disease	0.40
ALS	co_discussed	disease	0.40
DIABETES	co_discussed	disease	0.40
ATAXIA	co_discussed	disease	0.40
HUNTINGTON	co_discussed	disease	0.40
HUNTINGTON'S	co_discussed	disease	0.40
NEURON	co_discussed	cell_type	0.40
GLAUCOMA	regulates	disease	0.35
HUNTINGTON	therapeutic_target	disease	0.35
ALS	therapeutic_target	disease	0.35
CISPLATIN	activates	drug	0.35
NEURON	associated_with	cell_type	0.35
GLAUCOMA	interacts_with	disease	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

NEUROPATHY

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

Novel Therapy Index

CBS/PSP Supplements Guide

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

NTF4 Protein

Mitochondrial Quality Control

Growth Factor Therapies

Coenzyme Q10 for Neurodegeneration

CSF Neurofilament Light Chain (NfL) in Neurodegeneration

Niemann-Pick Disease Type C (NPC)

Spinal Cord Stimulation-Affected Neurons

ZDHHC13 — Zinc Finger DHHC-Type Containing 13

Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)

Synucleinopathies

KARS1

NDUFAF3 Gene

Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT06223360)